Adrenergic blockade in diabetic and uninephrectomized rats: Effects on renal size and on renal and urinary contents of epidermal growth factor

Nephron

Volumn 81, Issue 2, 1999, Pages 172-182

  Thulesen, Jesper ^a   Poulsen, Steen Seier ^b   Jørgensen, Per Erik ^b   Nexø, Ebba ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

Adrenergic antagonists; Diabetes mellitus; Epidermal growth factor; Kidney growth; Uninephrectomy

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; EPIDERMAL GROWTH FACTOR; MESSENGER RNA;

ADRENERGIC ACTIVITY; ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; KIDNEY DEVELOPMENT; KIDNEY PARENCHYMA; KIDNEY SIZE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; UNINEPHRECTOMY; URINE LEVEL;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY FUNCTION TESTS; NEPHRECTOMY; OLIGONUCLEOTIDE PROBES; ORGAN SIZE; PRAZOSIN; PROPRANOLOL; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0032993340     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045274     Document Type: Article

References (46)

1. Rasch R. Darup J: Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment. Diabetologia 1997;40:802-809.
2. Seyer-Hansen K: Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 1976; 51:551-555.
3. Seyer-Hansen K: Renal hypertrophy in experimental diabetes. Kidney Int 1983;23:643-646.
4. Reddi AS, Camerini-Davalos RA: Diabetic nephropathy. Arch Intern Med 1990;150:31-43.
5. Rasch R: Tubular lesions in streptozotocin-diabetic rats. Diabetologia 1984;27:32-37.
6. Poulsen SS, Nexø E. Olsen PS, Hess J, Kirkegaard P: Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry 1986;85:389-394.
7. Salido EC, Yen PH, Shapiro LJ, Fisher DA, Barajas L: In situ hybridization of prepro-epidermal growth factor mRNA in the mouse kidney. Am J Physiol 1989;256:F632-F638.
8. Jørgensen PE, Rasmussen TN, Olsen PS, Raaberg L, Poulsen SS, Nexø E: Renal uptake of epidermal growth factor from plasma in the rat. Regul Pept 1990;28:273-280.
9. Jørgensen PE, Hilchey SD, Nexø E, Poulsen SS, Quilley CP: Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol 1993;193:227-234.
10. Norman J, Tsau YK. Bacay A, Fine LG: Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: Role of the epidermal growth factor receptor. Clin Sei (Colch) 1990;78:445-450.
11. Humes HD, Cieslinski DA. Coumbra TM, Messana JM, Galvao C: Epidermal growth factor enhances renal tubular cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 1989;84:1757-1761.
12. Miller SB, Rogers SA, Estes CE, Hammerman MR: Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy. Am J Physiol 1992; 262:F1032-F1038.
13. Gilbert RE, Cox A, McNally PG, Wull L, Dziadek M, Cooper ME, Jerums G: Increased epidermal growth factor in experimental diabetes related kidney growth in rats. Diabetologia 1997;40:778-785.
14. Kanda S, Igawa T, Sakai H, Nomata K, Kanetche H, Saito Y: Anti-epidermal growth factor antibody inhibits compensatory renal hyperplasia but not hypertrophy after unilateral nephrectomy in mice. Biochem Biophys Res Commun 1992;187:1015-1021.
15. Jennische E, Andersson G, Hansson HA: Epidermal growth factor is expressed by cells in the distal tubules during postnephrectomy renal growth. Acta Physiol Scand 1987;129:449-450.
16. Thulesen J. Jørgensen PE, Torffvit O, Nexø E, Poulsen SS: Urinary excretion of epidermal growth factor and Tamm-Horsfall protein in three rat models with increased renal excretion of urine. Regul Pept 1997;72:179-186.
17. Olsen PS, Kirkegaard P, Poulsen SS, Nexø E: Adrenergic effects on renal secretion of epidermal growth factor in the rat. Regul Pept 1985; 11:17-25.
18. Dunbar JC, Coleman ER, Shatter LR, Marzouq L: Central adrenergic suppression augments the insulin and glucagon secretory, and the glucogenolytic responses in streptozotocin-diabetic rats. Horm Res 1991;36:80-85.
19. Bolli G, Cartechini MG, Campagnucci P, Malvicini S, Defeo P, Santeusanio F, Angeletti G, Brunetti P: Effect of metabolic control on urinary excretion and plasma levels of catecholamines in diabetes. Horm Metab Res 1979;11: 493-497.
20. Christensen NJ: Plasma norepinephrine and epinephrine in untreated diabetes during fasting after insulin administration. Diabetes 1974;23:1-8.
21. Kaul CL, Grewall RS: Increased urinary excretion of catecholamines and their metabolites in streptozotocin diabetic rats. Pharmacology 1980;21:223-228.
22. Seyer-Hansen K: Renal hypertrophy in experimental diabetes: A comparison to compensatory hypertrophy. Diabetologia 1978;14:325-328.
23. Flyvbjerg A, Thorlacius-Ussing O. Næraa R, Ingerslev J. Ørskov H: Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomised rats. Diabetologia 1988;31: 310-314.
24. Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, Ørskov H: Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth diabetes and uninephrectomized rats. Diabetologia 1989;32: 261-265.
25. 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 1983;25: 280-287.
26. Lepor H: Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia. Prostate 1990;3(suppl):75-84.
27. Wilde MI, Fitton A, Sorkin EM: Terazosin - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutical potential in benign prostatic hyperplasia. Drugs Aging 1993;3:258-277.
28. Jørgensen PE, Vinter-Jensen L, Nexø E: An immunoassay designed to quantitate different molecular forms of rat urinary epidermal growth factor with equimolar potency: Application on fresh rat urine. Scand J Clin Lab Invest 1996;56:25-36.
29. Owen JA, Iggo B, Scandrett FJ, Stewart CP: The determination of creatinine in plasma or serum and in urine: A critical examination. Biochem J 1954;58:426-437.
30. Kleinman KS, Fine LG: Prognostic implications of renal hypertrophy in diabetes mellitus. Diabetes Metab Rev 1988;4:179-189.
31. Sayed-Ahmed N, Besbas N, Mundy J, Muchaneta-Kubara E, Cope G, Pearson C, El Nahas M: Regulation of epidermal growth factor and its receptor in the kidney of rats with streptozotocin-induced diabetes. Exp Nephrol 1996;4: 330-339.
32. Lee DC, Chan DW. Chan SY: Expression of transforming growth factor alpha and epidermal growth factor in adult polycystic kidney disease. J Urol 1998;159:291-296.
33. 1receptor blockade. Am J Hypertens 1996;9:895-901.
34. Cooper ME, Allen TJ, O'Brien RC. Papazogloud D, Clarke BE. Jerums G, Doyle AE: Nephropathy in model combining genetic hypertension with experimental diabetes: Enalapril versus hydralazine and metoprolol therapy. Diabetes 1990;39:1575-1579.
35. Petitjean P, Vloemans M, Barthelmebs M, Stephan D, Grima M, Jund A, Imbs JL: Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats. Fundam Clin Pharmacol 1996;8: 356-365.
36. Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist JH, Ørskov H: Kidney IGF-1 mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 1990:33:334-338.
37. Asplin CM, Werner PL, Halter JB, Hollander PM, Palmer JP: Autonomic nervous system control of glucagon secretion during neuroglucopenia. Endocrinology 1983;112:1585-1589.
38. Szabo O, Szabo AJ: Evidence for an insulin-sensitive receptor in the central nervous system. Am J Physiol 1972;223:1349-1353.
39. Olsen PS, Kirkegaard P, Poulsen SS, Nexø E: Adrenergic effects on exocrine secretion of rat submandibular epidermal growth factor. Gut 1984;25:1234-1240.
40. Nexø E, Hollenberg MD, Bing J: Aggressive behaviour in mice provokes a marked increase in both plasma epidermal growth factor and renin. Acta Physiol Scand 1981;111:367-371.
41. Nexø E, Olsen PS, Poulsen SS: Exocrine and endocrine secretion of renin and epidermal growth factor from the mouse submandibular glands. Regul Pept 1984;8:327-334.
42. Nexø E, Hansen MR, Konradsen L: Human salivary epidermal growth factor, haptocorrin and amylase before and after prolonged exercise. Scand J Clin Lab Invest 1988;48:269-273.
43. Shafrir E: Diabetes in animals; in Porte D, Sherwin RS (eds): Diabetes mellitus, ed 5. Stamford, Conn., Appleton & Lange, 1997, p 303.
44. Kaplan NM: Effects of antihypertensive therapy on insulin resistance. Hypertension 1992; 19:1116-118.
45. Lafontan M, Berlan M, Carpene C: Fat cell adrenoceptors: Inter- and intraspecific differences and hormone regulation. Int J Obes 1985;9:117-122.
46. Jørgensen PE, Kamper AL, Munck O, Strandgaard S, Nexø E: Urinary excretion of epidermal growth factor in living human kidney donors and their recipients. Eur J Clin Invest 1995;25:442-446.